• Company Overview
    MORE

              The Beijing Infoark science and technology development limited company was established in 2003, the company mainly manages raw medical material, medicine intermediates, food additive, and health-care nutriment raw material.
              Many years experience of international trade management has caused the company to grow up to take the international trade as the main development direction, and take the world first-class high tech research, development and the product base as the backing, became the comprehensive company which involves the research, development, production, and sells.

    • NEWS
      MORE

      In October 25 to October 27, 2011
              In October 25 to October 27, 2011, Mr. Gong Hailing (General Manager of Beijing Infoark Co., Ltd. led international business dept. (9 peoples) participated successfully CPhI Exhibition in Frankfurt (booth number 60114CP) .
      During CPhI exhibition, we met customers for deeply communication in business, enhance mutual understanding and mutual trust, we obtain good effect!

    • Pharmaceutical Chemical
      MORE

      Corporate Responsibility at infoark - DOXYCYCLINE HCL
      - EPERISONE HCL
      - ERYTHROMYCIN THIOCYANATE
      - FLORFENICOL
      - LINCOMYCIN HCL
      - NICOTINAMIDE
      - NEOMYCIN SULPHATE
      - TIAMULIN HF 80%, 98%



      Intermediate
      MORE

      'Support My School' Campaign - Lobeline Hydrochloride
      - Rasagiline Mesylate
      - Ezetimibe
      - Repaglinide
      - Sorafenib
      - Peramivir
      - Pentazocine

      
    • Business Scope:
      • Pharmaceutical
      • Pharmaceutical intermediates
      • Food Additives
      • Health nutrition
    • Sales Network:
      • Europe
      • South America
      • Southeast Asia, East Asia
      • Middle East
      • Africa
    • Recruitment:
      • Foreign trade clerk
      • Product procurement
      • Foreign Trade Assistant
      • Foreign Trade Merchandiser
      • Domestic business manager
    • Contact
    •   
    •   
    •       
    •   
    •   
    •   
    •